Home » Tightened Conflict-of-Interest Policies Reflect New EMA Chief’s Influence
Tightened Conflict-of-Interest Policies Reflect New EMA Chief’s Influence
April 6, 2012
The European Medicines Agency (EMA) is increasing restrictions on the activities of its scientific experts and committee members in an updated conflict-of-interest policy that took effect March 4, less than a year after the last set of updates.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor